Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial.

1995120 citationsJournal Article

Authors

Aditya K. Gupta · University of Michigan–Ann Arbor

Jacques Grober · University of Michigan–Ann Arbor

T.A. HAMILTON · University of Michigan–Ann Arbor

Charles N. Ellis

Michael T. Siegel · University of Michigan–Ann Arbor

John J. Voorhees

W. Joseph McCune · Center for Rheumatology

Abstract

Sulfasalazine was effective in PsA, with efficacy observed as early as the 4th week of treatment. Longterm studies are needed to determine whether such therapy can modify disease outcome.

Topics & Keywords

Rheumatoid Arthritis Research and Therapies Psoriasis: Treatment and Pathogenesis Spondyloarthritis Studies and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 22, Issue 5, pp. 894-8

Field-Weighted Citation Impact: 0.99